PHS
COO icon

PFM Health Sciences’s Cooper Companies COO Stock Holding History

PFM Health Sciences’s Portfolio COO Stock Details COO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
220,890
+51,061
+30% +$3.34M 1.36% 24
2026
Q1 		$12.1M Buy
169,829
+69,027
+68% +$5.46M 1.11% 27
2025
Q4 		$8.26M Buy
100,802
+26,439
+36% +$1.98M 0.82% 41
2025
Q3 		$5.1M Buy
+74,363
New +$5.27M 0.39% 49
2014
Q1 		– Sell
-764,612
Closed -$23.7M – 81
2013
Q4 		$23.7M Buy
764,612
+386,444
+102% +$12.3M 0.48% 44
2013
Q3 		$12.3M Sell
378,168
-588
-0.2% -$19K 0.3% 53
2013
Q2 		$11.3M Buy
+378,756
New +$10.6M 0.23% 62

Other funds holding COO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.69B AUM 9.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PFM Health Sciences's COO Position: Q2 2026 in Review

PFM Health Sciences increased its Cooper Companies (COO) stake by 30% in Q2 2026, buying an estimated $3.34M and bringing the position to 220,890 shares worth $15.8M. The position accounts for 1.36% of the portfolio, ranked #24.

PFM Health Sciences first reported a position in COO in Q2 2013 and has held it in 7 quarters since. The position peaked at $23.7M in Q4 2013. 677 funds tracked by Wall St. Rank hold COO as of Q2 2026.

  • PFM Health Sciences held 220,890 shares of Cooper Companies worth $15.8M as of Q2 2026.
  • PFM Health Sciences bought 51,061 Cooper Companies shares in Q2 2026, an estimated $3.34M.
  • Cooper Companies made up 1.36% of PFM Health Sciences's portfolio in Q2 2026, its #24 holding.
  • PFM Health Sciences first reported a position in Cooper Companies in Q2 2013 and has held it in 7 quarters since.
  • PFM Health Sciences's Cooper Companies position peaked at $23.7M in Q4 2013.
  • 677 funds tracked by Wall St. Rank held Cooper Companies as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.